Skip to content

Presentations and Publications

Presentations

NTS-105 Decreases Cell Death After In Vitro Stretch Injury

This study demonstrated the ability of NTS-105 to reduce cell death at a wide range of concentrations in a preclinical model of TBI.

Advancements in the Development of Novel Neurosteroids for Treatment of Brian Injury

This presentation discusses advances in the development of novel neurosteroids for the treatment of traumatic brain injury.

Publications

NTS-105 decreased cell death and preserved long-term potentiation in an in vitro model of moderate traumatic brain injury.

Dwyer, et al. (Experimental Neurology 2023)

Neurosteroid receptor modulators for treating traumatic brain injury.

Verdoorn, Parry, et al. (Neurotherapeutics 2023)

Pharmacological characterization of a novel neuroactive steroid prodrug, NTS-104 and its neuroprotective activity in experimental stroke models.

Zhang, et al. (Stroke 2022)

Abstract WMP9: Pharmacological Characterization Of The Water Soluble Neurosteroid NTS-104 In The Rat Embolic Stroke Model.

Byrne, Robin, et al. (Stroke 2022)
Top